Oncologic emergencies and urgencies: A comprehensive review

BE Gould Rothberg, TE Quest… - CA: a cancer journal …, 2022 - Wiley Online Library
Patients with advanced cancer generate 4 million visits annually to emergency departments
(EDs) and other dedicated, high‐acuity oncology urgent care centers. Because of both the …

Current perspectives on mesenchymal stromal cell therapy for graft versus host disease

N Kadri, S Amu, E Iacobaeus, E Boberg… - Cellular & Molecular …, 2023 - nature.com
Graft versus host disease (GvHD) is the clinical condition in which bone marrow-derived
mesenchymal stromal cells (MSCs) have been most frequently studied. In this review, we …

Axatilimab in recurrent or refractory chronic graft-versus-host disease

D Wolff, C Cutler, SJ Lee, I Pusic… - … England Journal of …, 2024 - Mass Medical Soc
Background Colony-stimulating factor 1 receptor (CSF1R)–dependent monocytes and
macrophages are key mediators of chronic graft-versus-host disease (GVHD), a major long …

The role of interferon-γ in autoimmune polyendocrine syndrome type 1

V Oikonomou, G Smith, GM Constantine… - … England Journal of …, 2024 - Mass Medical Soc
Background Autoimmune polyendocrine syndrome type 1 (APS-1) is a life-threatening,
autosomal recessive syndrome caused by autoimmune regulator (AIRE) deficiency. In APS …

Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome

JM Vinnakota, F Biavasco, M Schwabenland… - Nature cancer, 2024 - nature.com
Cancer immunotherapy with chimeric antigen receptor (CAR) T cells can cause immune
effector cell-associated neurotoxicity syndrome (ICANS). However, the molecular …

Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story

M Bonelli, A Kerschbaumer, K Kastrati… - Annals of the rheumatic …, 2024 - Elsevier
Fundamental insight gained over the last decades led to the discovery of cytokines as
pivotal drivers of inflammatory diseases such as rheumatoid arthritis, psoriasis/psoriasis …

Axatilimab for chronic graft-versus-host disease after failure of at least two prior systemic therapies: results of a phase I/II study

CL Kitko, M Arora, Z DeFilipp, MA Zaid… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Chronic graft-versus-host disease (cGVHD) remains the major cause of late
morbidity after allogeneic hematopoietic cell transplantation. Colony-stimulating factor 1 …

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer

C Xue, Q Yao, X Gu, Q Shi, X Yuan, Q Chu… - Signal transduction and …, 2023 - nature.com
The Janus kinase (JAK) signal transducer and activator of transcription (JAK-STAT) pathway
is an evolutionarily conserved mechanism of transmembrane signal transduction that …

IFNγ-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy

L Beziaud, CM Young, AM Alonso, M Norkin… - Cell Stem Cell, 2023 - cell.com
Despite the remarkable success of immune checkpoint blockade (ICB) therapy, most cancer
patients still do not respond. We now find that immunotherapy can induce stem-like …

JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition

Y Luo, M Alexander, M Gadina, JJ O'Shea… - Journal of Allergy and …, 2021 - Elsevier
Since its discovery, the Janus kinase-signal transduction and activation of transcription (JAK-
STAT) pathway has become recognized as a central mediator of widespread and varied …